Expanded Access to Experimental Biologics
Expanded access, sometimes called “compassionate use,” is the use outside of a clinical trial of an investigational medical product (i.e., one that has not been approved by FDA). FDA is committed to increasing awareness of and knowledge about its expanded access programs and the procedures for obtai
Recommend0 recommendationsPublished in US National Health Agency Sources